2 completed, 2 terminated, 2 withdrawn. 4 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 2, Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow sabizabulin: new trials by email Literature Review of sabizabulin trials Research Report on sabizabulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer Sabizabulin, Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator - Metastatic Breast Cancer | Phase 2 | Withdrawn | Veru Inc. | 2023-03-15 | 2023-03-24 | |
| P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC . Sabizabulin, Sacituzumab Govitecan-hziy, Sabizabulin/Sacituzumab govitecan-hziy Combo - Metastatic Triple Negative Breast Cancer | Phase 2 | Withdrawn | Veru Inc. | 2021-12-30 | 2022-02-08 | |
| Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent VERU-111, Enzalutamide, Abiraterone - Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer | Phase 3 | Terminated | Veru Inc. | 105 | 2021-06-24 | 2024-02-05 |
| VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study VERU-111 - SARS-CoV Infection | Phase 3 | Completed | Veru Inc. | 204 | 2021-05-18 | 2026-09-10 |
| COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 Veru-111 - Respiratory Distress Syndrome, Adult | Phase 2 | Completed | Veru Inc. | 39 | 2020-06-18 | 2022-10-27 |
| To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer VERU-111 - Metastatic Castration Resistant Prostate Cancer | Phase 1 / Phase 2 | Terminated | Veru Inc. | 80 | 2019-01-18 | 2023-09-26 |
Breast Neoplasms (1) · Prostatic Neoplasms, Castration-Resistant (1) · Respiratory Distress Syndrome (1) · Severe Acute Respiratory Syndrome (1) · Triple Negative Breast Neoplasms (1)
Veru Inc. (6)
United States (5) · Argentina (1) · Brazil (1) · Bulgaria (1) · Colombia (1) · Mexico (1)